All major world menopause guidelines are now consistent with advice that MHT is appropriate treatment to offer to symptomatic healthy women “around the time of menopause”. This presentation will focus on the practicalities of the menopause consultation in 2018 and on how to approach the prescribing of MHT in an individual woman. How to choose, initiate and monitor the different forms of MHT will be discussed and will include the newer preparations of MHT available as options in Australia and New Zealand.

RACGP CPD Program 2020-22 Triennium, 
Activity CPD: 495006 0.5 Hours 

ACRRM: Activity CPD 29257 1 Hour

Access to this course is $10 (GST INC) by payment through PayPal. 

Note: You do not require a PayPal account as the process accepts major credit cards.